Biologics Market size was valued at US$ 360.17 Bn. in 2022 and the total revenue is expected to grow at 9.1 % through 2023 to 2029, reaching nearly US$ 662.66 Bn.Biologics Market Overview:
Biologics are drugs made from complex molecules manufactured using living plants, microorganisms, or animal cells. The Biologics drugs market has been exhibiting an aggressive competition divided among a handful of household organizations and count of the world’s best pharmaceutical companies. There are some examples of biologics such as Lantus (insulin glargine), Humira (adalimumab), Herceptin (trastuzumab), Avastin (bevacizumab), and Botox (onabotulinumtoxina). Biologics have witnessed millions of dollars put in by pharmaceutical behemoths like Sandoz, AstraZeneca, Novartis, and Eli Lilly and Co., and others.To know about the Research Methodology :- Request Free Sample Report
Global Biologics Market Dynamics:
In the past five years, over US$ 1.5 billion have been invested by top 10 pharmaceutical giants which have interpreted into capacity expansion and focused research and development. Pharmaceutical companies are earning strong revenues through best prices value increased in their profit margins xx%. Factors like product approvals and the ability of biologics to effectively treat significantly complex diseases, which was close to incredible earlier, have been key for biologics market growth. Pharmaceutical companies patenting biologics products have been projected to make healthy gains during the forecast period. With the vigorous growth in the biopharmaceutical industry, over 14% of biomolecules that enter phase I of clinical trials have been expected to be likely approved as a drug. Growing annual product approvals and strong biologics channel has been an indication of robust development of the world biologics market. For example, the anti-inflammatory drug Humira is not only the best-selling drug, but it is also one of the best-selling drugs globally. But, high capital investment essential for research and development could hinder the demand in the international biologics market. Only biopharmaceutical companies have been observed to enter the market because of a costly initial setup. A successful product launch primarily requires an over US$1.0 billion investment and takes nearly 9 years. Furthermore, the regulatory approval of biologics is quite detailed since the molecules are complex. Manufacturers in Biologics are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.Global Biologics Market Segment Analysis:
The global Biologics Market is segmented by Product and Application. Based on Product, the global Biologics market is segmented into Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell Therapy, and Gene Therapy. The Monoclonal Antibodies segment held the largest market share of 42.9% in 2022. Extensive growth is credited to the increasing demand for personalized therapies in various regions. Additionally, extensive researches in antibodies to discover targeted therapies for a variety of diseases, like different types of infections, cancers, and various immunological disorders, are projected to propel the market. Based on Application, the global Biologics market is segmented into Oncology, Infectious Diseases, Immunology, and Autoimmune Diseases. The Immunology segment held the largest market share of xx% in 2022 and it is expected to grow at the highest CAGR of xx% in the global Biologics market during the forecast period. Biologics are utilised to treat autoimmune illnesses such as inflammatory arthritis, rheumatoid arthritis, and psoriatic arthritis, which is driving the market growth.
Global Biologics Market Regional Insights:
North America held the largest market share of 51% in 2022 and is expected to remain its leading position in the global Biologics market during the forecast period. Because of, growth in this regional market is attributed to intensive research and development activities, novel drug formulations, and a large number of clinical trials focused on large-molecule drug discovery. Asia Pacific held the 2nd largest market share of 21% in 2022. Because of the rising prevalence of chronic conditions such as diabetes, as well as the increased number of healthcare tourists in the regions of the world. The objective of the report is to present a comprehensive analysis of the global Biologics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the global Biologics Market dynamic, structure by analyzing the market segments and project the global Biologics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Biologics Market make the report investor’s guide.Global Biologics Market Scope: Inquire before buying
Biologics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 360.17 Bn. Forecast Period 2023 to 2029 CAGR: 9.1% Market Size in 2029: US $ 662.66 Bn. Segments Covered: by Disease Category • Oncology • Infectious Diseases • Immunological Disorders • Cardiovascular Disorders • Hematological Disorders • Others by Manufacturing • In-house • Outsource by Product • Monoclonal Antibodies By application o Diagnostic o Therapeutic o Protein Purification o Others
By type o Murine o Chimeric o Humanized o Human o Others
• Vaccines • Recombinant Proteins • Antisense, RNAi, & Molecular Therapy • Othersby Source • Microbial • Mammalian • Others Global Biologics Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Global Biologics Market Key Players
• Sandoz • Pfizer • Teva Pharmaceutical • Celltrion • Biocon • Amgen • Samsung Biologics • Mylan • Dr. Reddy's Laboratories • Stada Arzneimittel AG • Pernix Therapeutics • Purdue Pharma L.P. • Sanofi Pasteur • SkyePharma • Takeda Pharmaceutical Company • AbbVie Inc. • Eli Lilly and Company • F. Hoffmann-La Roche AG • GlaxoSmithkline PLC • G. Chem Ltd. • AstraZeneca PlcFrequently Asked Questions:
1] What segments are covered in Biologics Market report? Ans. The segments covered in Biologics Market report are based on Product and Application. 2] Which region is expected to hold the highest share in the global Biologics Market? Ans. North America is expected to hold the highest share in the global Biologics Market. 3] What is the market size of global Biologics Market by 2029? Ans. The market size of global Biologics Market by 2029 is US $ 662.66 Bn. 4] Who are the top key players in the global Biologics Market? Ans. Sandoz, Pfizer, Teva Pharmaceutical, Celltrion and Biocon are the top key players in the global Biologics Market. 5] What was the market size of global Biologics Market in 2022? Ans. The market size of global Biologics Market in 2022 was US $ 360.17 Bn. 6] By Application, What segments are covered in global Biologics Market report? Ans. The segments covered in global Biologics Market report by application are Oncology, Infectious Diseases, Immunology and Autoimmune Diseases.
1. Biologics Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Biologics Market: Dynamics 2.1. Biologics Market Trends 2.2. Biologics Market Dynamics 2.2.1. Biologics Market Drivers 2.2.2. Biologics Market Restraints 2.2.3. Biologics Market Opportunities 2.2.4. Biologics Market Challenges 2.3. PORTER’s Five Forces Analysis 2.3.1. Bargaining Power of Suppliers 2.3.2. Bargaining Power of Buyers 2.3.3. Threat Of New Entrants 2.3.4. Threat Of Substitutes 2.3.5. Intensity Of Rivalry 2.4. PESTLE Analysis 2.5. Digital Holographic Microscopy Price Trend Analysis (2021-22) 2.6. Software Usage in Medical Devices (2017 &2022) 2.7. Key Opinion Leader Analysis for Digital Holographic Microscopy Industry 2.8. Government Investments and Initiatives for Digital Holographic Microscopy Industry 2.9. The Global Pandemic Impact on Biologics Market 2.10. Regulatory Landscape by Region 2.10.1. North America 2.10.2. Europe 2.10.3. Asia Pacific 2.10.4. Middle East and Africa 2.10.5. South America 3. Biologics Market: Global Market Size and Forecast By Segmentation by Demand and Supply Side (By Value in USD Million, Volume in Units) (2022-2029) 3.1. Biologics Market Size and Forecast, By Disease Category (2022-2029) 3.1.1. Oncology 3.1.2. Infectious Diseases 3.1.3. Immunological Disorders 3.1.4. Cardiovascular Disorders 3.1.5. Hematological Disorders 3.1.6. Others 3.2. Biologics Market Size and Forecast, By Manufacturing (2022-2029) 3.2.1. In-house 3.2.2. Outsource 3.3. Biologics Market Size and Forecast, By Product (2022-2029) 3.3.1. Monoclonal Antibodies 3.3.1.1. By application 3.3.1.1.1. Diagnostic 3.3.1.1.2. Therapeutic 3.3.1.1.3. Protein Purification 3.3.1.1.4. Others 3.3.1.2. By Type 3.3.1.2.1. Murine 3.3.1.2.2. Chimeric 3.3.1.2.3. Humanized 3.3.1.2.4. Human 3.3.1.2.5. Others 3.3.2. Vaccines 3.3.3. Recombinant Proteins 3.3.4. Antisense, RNAi, & Molecular Therapy 3.3.5. Others 3.4. Biologics Market Size and Forecast, By Source (2022-2029) 3.4.1. Microbial 3.4.2. Mammalian 3.4.3. Others 3.5. Biologics Market Size and Forecast, By Region (2022-2029) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Biologics Market Size and Forecast By Segmentation by Demand and Supply Side (By Value in USD Million) (2022-2029) 4.1. North America Biologics Market Size and Forecast, By Disease Category (2022-2029) 4.1.1. Oncology 4.1.2. Infectious Diseases 4.1.3. Immunological Disorders 4.1.4. Cardiovascular Disorders 4.1.5. Hematological Disorders 4.1.6. Others 4.2. North America Biologics Market Size and Forecast, By Manufacturing (2022-2029) 4.2.1. In-house 4.2.2. Outsource 4.3. North America Biologics Market Size and Forecast, By Product (2022-2029) 4.3.1. Monoclonal Antibodies 4.3.1.1. By application 4.3.1.1.1. Diagnostic 4.3.1.1.2. Therapeutic 4.3.1.1.3. Protein Purification 4.3.1.1.4. Others 4.3.1.2. By Type 4.3.1.2.1. Murine 4.3.1.2.2. Chimeric 4.3.1.2.3. Humanized 4.3.1.2.4. Human 4.3.1.2.5. Others 4.3.2. Vaccines 4.3.3. Recombinant Proteins 4.3.4. Antisense, RNAi, & Molecular Therapy 4.3.5. Others 4.4. North America Biologics Market Size and Forecast, By Source (2022-2029) 4.4.1. Microbial 4.4.2. Mammalian 4.4.3. Others 4.5. Biologics Market Size and Forecast, By Country (2022-2029) 4.5.1. United States 4.5.1.1. United States Biologics Market Size and Forecast, By Disease Category (2022-2029) 4.5.1.1.1. Oncology 4.5.1.1.2. Infectious Diseases 4.5.1.1.3. Immunological Disorders 4.5.1.1.4. Cardiovascular Disorders 4.5.1.1.5. Hematological Disorders 4.5.1.1.6. Others 4.5.1.2. United States Biologics Market Size and Forecast, By Manufacturing (2022-2029) 4.5.1.2.1. In-house 4.5.1.2.2. Outsource 4.5.1.3. United States Biologics Market Size and Forecast, By Product (2022-2029) 4.5.2. Monoclonal Antibodies 4.5.2.1. By application 4.5.2.1.1. Diagnostic 4.5.2.1.2. Therapeutic 4.5.2.1.3. Protein Purification 4.5.2.1.4. Others 4.5.2.2. By Type 4.5.2.2.1. Murine 4.5.2.2.2. Chimeric 4.5.2.2.3. Humanized 4.5.2.2.4. Human 4.5.2.2.5. Others 4.5.3. Vaccines 4.5.4. Recombinant Proteins 4.5.5. Antisense, RNAi, & Molecular Therapy 4.5.6. Others 4.5.6.1. United States Biologics Market Size and Forecast, By Source (2022-2029) 4.5.6.1.1. Microbial 4.5.6.1.2. Mammalian 4.5.6.1.3. Others 4.5.7. Canada 4.5.7.1. Canada Biologics Market Size and Forecast, By Disease Category (2022-2029) 4.5.7.1.1. Oncology 4.5.7.1.2. Infectious Diseases 4.5.7.1.3. Immunological Disorders 4.5.7.1.4. Cardiovascular Disorders 4.5.7.1.5. Hematological Disorders 4.5.7.1.6. Others 4.5.7.2. Canada Biologics Market Size and Forecast, By Manufacturing (2022-2029) 4.5.7.2.1. In-house 4.5.7.2.2. Outsource 4.5.7.3. Canada Biologics Market Size and Forecast, By Product (2022-2029) 4.5.8. Monoclonal Antibodies 4.5.8.1. By application 4.5.8.1.1. Diagnostic 4.5.8.1.2. Therapeutic 4.5.8.1.3. Protein Purification 4.5.8.1.4. Others 4.5.8.2. By Type 4.5.8.2.1. Murine 4.5.8.2.2. Chimeric 4.5.8.2.3. Humanized 4.5.8.2.4. Human 4.5.8.2.5. Others 4.5.9. Vaccines 4.5.10. Recombinant Proteins 4.5.11. Antisense, RNAi, & Molecular Therapy 4.5.12. Others 4.5.12.1. Canada Biologics Market Size and Forecast, By Source (2022-2029) 4.5.12.1.1. Microbial 4.5.12.1.2. Mammalian 4.5.12.1.3. Others 4.5.13. Mexico 4.5.13.1. Mexico Biologics Market Size and Forecast, By Disease Category (2022-2029) 4.5.13.1.1. Oncology 4.5.13.1.2. Infectious Diseases 4.5.13.1.3. Immunological Disorders 4.5.13.1.4. Cardiovascular Disorders 4.5.13.1.5. Hematological Disorders 4.5.13.1.6. Others 4.5.13.2. Mexico Biologics Market Size and Forecast, By Manufacturing (2022-2029) 4.5.13.2.1. In-house 4.5.13.2.2. Outsource 4.5.13.3. Mexico Biologics Market Size and Forecast, By Product (2022-2029) 4.5.14. Monoclonal Antibodies 4.5.14.1. By application 4.5.14.1.1. Diagnostic 4.5.14.1.2. Therapeutic 4.5.14.1.3. Protein Purification 4.5.14.1.4. Others 4.5.14.2. By Type 4.5.14.2.1. Murine 4.5.14.2.2. Chimeric 4.5.14.2.3. Humanized 4.5.14.2.4. Human 4.5.14.2.5. Others 4.5.15. Vaccines 4.5.16. Recombinant Proteins 4.5.17. Antisense, RNAi, & Molecular Therapy 4.5.18. Others 4.5.18.1.1. 4.5.18.2. Mexico Biologics Market Size and Forecast, By Source (2022-2029) 4.5.18.2.1. Microbial 4.5.18.2.2. Mammalian 4.5.18.2.3. Others 5. Europe Biologics Market Size and Forecast By Segmentation by Demand and Supply Side (By Value in USD Million) (2022-2029) 5.1. Europe Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.2. Europe Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.3. Europe Biologics Market Size and Forecast, By Product (2022-2029) 5.4. Europe Biologics Market Size and Forecast, By Source(2022-2029) 5.5. Europe Biologics Market Size and Forecast, By Country (2022-2029) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.1.2. United Kingdom Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.1.3. United Kingdom Biologics Market Size and Forecast, By Product (2022-2029) 5.5.1.4. United Kingdom Biologics Market Size and Forecast, By Source(2022-2029) 5.5.2. France 5.5.2.1. France Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.2.2. France Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.2.3. France Biologics Market Size and Forecast, By Product (2022-2029) 5.5.2.4. France Biologics Market Size and Forecast, By Source(2022-2029) 5.5.3. Germany 5.5.3.1. Germany Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.3.2. Germany Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.3.3. Germany Biologics Market Size and Forecast, By Product (2022-2029) 5.5.3.4. Germany Biologics Market Size and Forecast, By Source(2022-2029) 5.5.4. Italy 5.5.4.1. Italy Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.4.2. Italy Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.4.3. Italy Biologics Market Size and Forecast, By Product (2022-2029) 5.5.4.4. Italy Biologics Market Size and Forecast, By Source(2022-2029) 5.5.5. Spain 5.5.5.1. Spain Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.5.2. Spain Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.5.3. Spain Biologics Market Size and Forecast, By Product (2022-2029) 5.5.5.4. Spain Biologics Market Size and Forecast, By Source(2022-2029) 5.5.6. Sweden 5.5.6.1. Sweden Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.6.2. Sweden Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.6.3. Sweden Biologics Market Size and Forecast, By Product (2022-2029) 5.5.6.4. Sweden Biologics Market Size and Forecast, By Source(2022-2029) 5.5.7. Austria 5.5.7.1. Austria Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.7.2. Austria Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.7.3. Austria Biologics Market Size and Forecast, By Product (2022-2029) 5.5.7.4. Austria Biologics Market Size and Forecast, By Source(2022-2029) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Biologics Market Size and Forecast, By Disease Category (2022-2029) 5.5.8.2. Rest of Europe Biologics Market Size and Forecast, By Manufacturing (2022-2029) 5.5.8.3. Rest of Europe Biologics Market Size and Forecast, By Product (2022-2029) 5.5.8.4. Rest of Europe Biologics Market Size and Forecast, By Source(2022-2029) 6. Asia Pacific Biologics Market Size and Forecast By Segmentation by Demand and Supply Side (By Value in USD Million) (2022-2029) 6.1. Asia Pacific Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.2. Asia Pacific Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.3. Asia Pacific Biologics Market Size and Forecast, By Product (2022-2029) 6.4. Asia Pacific Biologics Market Size and Forecast, By Source(2022-2029) 6.5. Asia Pacific Biologics Market Size and Forecast, By Country (2022-2029) 6.5.1. China 6.5.1.1. China Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.1.2. China Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.1.3. China Biologics Market Size and Forecast, By Product (2022-2029) 6.5.1.4. China Biologics Market Size and Forecast, By Source(2022-2029) 6.5.2. South Korea 6.5.2.1. South Korea Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.2.2. South Korea Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.2.3. South Korea Biologics Market Size and Forecast, By Product (2022-2029) 6.5.2.4. South Korea Biologics Market Size and Forecast, By Source(2022-2029) 6.5.3. Japan 6.5.3.1. Japan Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.3.2. Japan Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.3.3. Japan Biologics Market Size and Forecast, By Product (2022-2029) 6.5.3.4. Japan Biologics Market Size and Forecast, By Source(2022-2029) 6.5.4. India 6.5.4.1. India Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.4.2. India Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.4.3. India Biologics Market Size and Forecast, By Product (2022-2029) 6.5.4.4. India Biologics Market Size and Forecast, By Source(2022-2029) 6.5.5. Australia 6.5.5.1. Australia Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.5.2. Australia Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.5.3. Australia Biologics Market Size and Forecast, By Product (2022-2029) 6.5.5.4. Australia Biologics Market Size and Forecast, By Source(2022-2029) 6.5.6. Indonesia 6.5.6.1. Indonesia Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.6.2. Indonesia Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.6.3. Indonesia Biologics Market Size and Forecast, By Product (2022-2029) 6.5.6.4. Indonesia Biologics Market Size and Forecast, By Source (2022-2029) 6.5.7. Malaysia 6.5.7.1. Malaysia Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.7.2. Malaysia Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.7.3. Malaysia Biologics Market Size and Forecast, By Product (2022-2029) 6.5.7.4. Malaysia Biologics Market Size and Forecast, By Source (2022-2029) 6.5.8. Vietnam 6.5.8.1. Vietnam Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.8.2. Vietnam Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.8.3. Vietnam Biologics Market Size and Forecast, By Product (2022-2029) 6.5.8.4. Vietnam Biologics Market Size and Forecast, By Source(2022-2029) 6.5.9. Taiwan 6.5.9.1. Taiwan Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.9.2. Taiwan Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.9.3. Taiwan Biologics Market Size and Forecast, By Product (2022-2029) 6.5.9.4. Taiwan Biologics Market Size and Forecast, By Source (2022-2029) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Biologics Market Size and Forecast, By Disease Category (2022-2029) 6.5.10.2. Rest of Asia Pacific Biologics Market Size and Forecast, By Manufacturing (2022-2029) 6.5.10.3. Rest of Asia Pacific Biologics Market Size and Forecast, By Product (2022-2029) 6.5.10.4. Rest of Asia Pacific Biologics Market Size and Forecast, By Source (2022-2029) 7. Middle East and Africa Biologics Market Size and Forecast By Segmentation by Demand and Supply Side (By Value in USD Million) (2022-2029) 7.1. Middle East and Africa Biologics Market Size and Forecast, By Disease Category (2022-2029) 7.2. Middle East and Africa Biologics Market Size and Forecast, By Manufacturing (2022-2029) 7.3. Middle East and Africa Biologics Market Size and Forecast, By Product (2022-2029) 7.4. Middle East and Africa Biologics Market Size and Forecast, By Source(2022-2029) 7.5. Middle East and Africa Biologics Market Size and Forecast, By Country (2022-2029) 7.5.1. South Africa 7.5.1.1. South Africa Biologics Market Size and Forecast, By Disease Category (2022-2029) 7.5.1.2. South Africa Biologics Market Size and Forecast, By Manufacturing (2022-2029) 7.5.1.3. South Africa Biologics Market Size and Forecast, By Product (2022-2029) 7.5.1.4. South Africa Biologics Market Size and Forecast, By Source(2022-2029) 7.5.2. GCC 7.5.2.1. GCC Biologics Market Size and Forecast, By Disease Category (2022-2029) 7.5.2.2. GCC Biologics Market Size and Forecast, By Manufacturing (2022-2029) 7.5.2.3. GCC Biologics Market Size and Forecast, By Product (2022-2029) 7.5.2.4. GCC Biologics Market Size and Forecast, By Source(2022-2029) 7.5.3. Nigeria 7.5.3.1. Nigeria Biologics Market Size and Forecast, By Disease Category (2022-2029) 7.5.3.2. Nigeria Biologics Market Size and Forecast, By Manufacturing (2022-2029) 7.5.3.3. Nigeria Biologics Market Size and Forecast, By Product (2022-2029) 7.5.3.4. Nigeria Biologics Market Size and Forecast, By Source(2022-2029) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Biologics Market Size and Forecast, By Disease Category (2022-2029) 7.5.4.2. Rest of ME&A Biologics Market Size and Forecast, By Manufacturing (2022-2029) 7.5.4.3. Rest of ME&A Biologics Market Size and Forecast, By Product (2022-2029) 7.5.4.4. Rest of ME&A Biologics Market Size and Forecast, By Source(2022-2029) 8. South America Biologics Market Size and Forecast By Segmentation by Demand and Supply Side (By Value in USD Million) (2022-2029 8.1. South America Biologics Market Size and Forecast, By Disease Category (2022-2029) 8.2. South America Biologics Market Size and Forecast, By Manufacturing (2022-2029) 8.3. South America Biologics Market Size and Forecast, By Product (2022-2029) 8.4. South America Biologics Market Size and Forecast, By Source(2022-2029) 8.5. South America Biologics Market Size and Forecast, By Country (2022-2029) 8.5.1. Brazil 8.5.1.1. Brazil Biologics Market Size and Forecast, By Disease Category (2022-2029) 8.5.1.2. Brazil Biologics Market Size and Forecast, By Manufacturing (2022-2029) 8.5.1.3. Brazil Biologics Market Size and Forecast, By Product (2022-2029) 8.5.1.4. Brazil Biologics Market Size and Forecast, By Source(2022-2029) 8.5.2. Argentina 8.5.2.1. Argentina Biologics Market Size and Forecast, By Disease Category (2022-2029) 8.5.2.2. Argentina Biologics Market Size and Forecast, By Manufacturing (2022-2029) 8.5.2.3. Argentina Biologics Market Size and Forecast, By Product (2022-2029) 8.5.2.4. Argentina Biologics Market Size and Forecast, By Source(2022-2029) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Biologics Market Size and Forecast, By Disease Category (2022-2029) 8.5.3.2. Rest Of South America Biologics Market Size and Forecast, By Manufacturing (2022-2029) 8.5.3.3. Rest Of South America Biologics Market Size and Forecast, By Product (2022-2029) 8.5.3.4. Rest Of South America Biologics Market Size and Forecast, By Source(2022-2029) 9. Global Biologics Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Product Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Biologics Market Companies, By market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Sandoz 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Pfizer 10.3. Teva Pharmaceutical 10.4. Celltrion 10.5. Biocon 10.6. Amgen 10.7. Samsung Biologics 10.8. Mylan 10.1.9. Dr. Reddy's Laboratories 10.10. Stada Arzneimittel AG 10.11. Pernix Therapeutics 10.12. Purdue Pharma L.P. 10.13. Sanofi Pasteur 10.14. SkyePharma 10.15. Takeda Pharmaceutical Company 10.16. AbbVie Inc. 10.17. Eli Lilly and Company 10.18. F. Hoffmann-La Roche AG 10.19. GlaxoSmithkline PLC 10.20. G. Chem Ltd. 10.21. AstraZeneca Plc 11. Key Findings 12. Industry Recommendations 13. Digital Holographic Microscopy: Research Methodology